BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  GEA Pharma Systems Release: Leading Contract Manufacturer Penn Pharma in UK Has Chosen GEA Pharma Systems as Key Supplier to Provide a Fully Integrated Production Line for Contained Development and Production

  June 6, 2012

   · 

  3 min read
• Drug Development

  Silence Therapeutics plc Announces Safe and Effective Dose Successfully Identified in Phase I Study of Atu027 and Potential Fund Raising

  June 6, 2012

   · 

  5 min read
• Drug Development

  Abbott Laboratories Presents Phase 3 Study Results for Investigational Use of HUMIRA® (Adalimumab) in Patients with Active Peripheral Spondyloarthritis

  June 6, 2012

   · 

  7 min read
• Pharm Country

  Mylan Inc. Launches Generic Version of Epivir(R) Film Coated Tablets in the UK and Italy, its First Generic ARV Launch in Europe

  June 6, 2012

   · 

  1 min read
• Drug Development

  FINOX Biotech Relaese: r-FSH Biosimilar Meets Primary Endpoint in Phase III Pivotal Study

  June 6, 2012

   · 

  3 min read
• Drug Development

  Generex Biotechnology Corporation Announces American Society of Clinical Oncology 2012 Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology

  June 6, 2012

   · 

  5 min read
• Drug Development

  Debiopharm Presented Results at the American Society of Clinical Oncology 2012 Annual Meeting - Results of Phase I Study With Debio 0932, an Oral HSP90 Inhibitor in Patients With Solid Tumours

  June 6, 2012

   · 

  4 min read
• Sony DADC BioSciences Walks Away With Best New Company 2012 Award at the European Life Science Awards

  June 6, 2012

   · 

  1 min read
• Drug Development

  Rhythm Initiates Phase 2 Clinical Trial of Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis

  June 6, 2012

   · 

  2 min read
• American Society of Clinical Oncology 2012: Show Me the Overall Survival Data!

  June 6, 2012

   · 

  6 min read